DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

15.36 0.25 (1.65%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLDX $15.36 1.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.10
Previous Close $15.11
Daily Range $14.86 - $15.46
52-Week Range $11.93 - $32.82
Market Cap $1.5B
P/E Ratio -11.45
Dividend (Yield) $0.00 (0.0%)
Volume 1,376,466
Average Daily Volume 2,024,400
Current FY EPS -$1.37




Drug Makers

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website:

News & Commentary Rss Feed

Why Shares of Celldex Therapeutics, Inc. Soared on Tuesday

This biotech is on a roller coaster that's not uncommon for the sector.

Insider Trading Alert - SWI, CLDX And CLGX Traded By Insiders

Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session

Perilous Reversal Stock: Celldex Therapeutics (CLDX)

3 Top Small-Cap Biotech Stocks to Buy Right Now

Aratana Therapeutics, Celldex Therapeutics, and Five Prime Therapeutics have been feeling the wrath of this moody market of late. Here's why one Fool believes the steep sell-offs in these names represent a compelling buying opportunity now.

Northwest Bio Forced to Temporarily Halt Study of Brain Tumor Vaccine

5 Small Biotech Stocks That Could Get Hotter Than the August Heat

These small biotechs hold the potential to add sizzle to investors' portfolios.

Vascular Biogenics: 3x Upside Potential In Tumor Angiogenesis Inhibition

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio

See More CLDX News...

CLDX's Top Competitors

CLDX $15.36 (1.65%)
Current stock: CLDX
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB